| GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer Q Wu, W Ba-Alawi, G Deblois, J Cruickshank, S Duan, E Lima-Fernandes, ... Nature communications 11 (1), 4205, 2020 | 176 | 2020 |
| PRMT inhibition induces a viral mimicry response in triple-negative breast cancer Q Wu, DY Nie, W Ba-Alawi, YS Ji, ZW Zhang, J Cruickshank, J Haight, ... Nature chemical biology 18 (8), 821-830, 2022 | 48 | 2022 |
| A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization D Dilworth, RP Hanley, R Ferreira de Freitas, A Allali-Hassani, M Zhou, ... Nature chemical biology 18 (1), 56-63, 2022 | 44 | 2022 |
| Risk of neurological toxicities following the use of different immune checkpoint inhibitor regimens in solid tumors: a systematic review and meta-analysis M Xu, Y Nie, Y Yang, YT Lu, Q Su The neurologist 24 (3), 75-83, 2019 | 43 | 2019 |
| Discovery of a potent and selective targeted NSD2 degrader for the reduction of H3K36me2 RP Hanley, DY Nie, JR Tabor, F Li, A Sobh, C Xu, NK Barker, D Dilworth, ... Journal of the American Chemical Society 145 (14), 8176-8188, 2023 | 17 | 2023 |
| Validating small molecule chemical probes for biological discovery V Vu, MM Szewczyk, DY Nie, CH Arrowsmith, D Barsyte-Lovejoy Annual review of biochemistry 91, 61-87, 2022 | 16 | 2022 |
| TAOK3, a Regulator of LCK–SHP-1 Crosstalk during TCR Signaling JVS Ormonde, Y Nie, J Madrenas Critical Reviews™ in Immunology 39 (1), 2019 | 6 | 2019 |
| Recruitment of FBXO22 for Targeted Degradation of NSD2 DY Nie, JR Tabor, J Li, M Kutera, J St-Germain, RP Hanley, E Wolf, ... bioRxiv, 2023.11. 01.564830, 2023 | 3 | 2023 |
| Altered RNA splicing initiates the viral mimicry response from inverted SINEs following type I PRMT inhibition in Triple-Negative Breast Cancer C Arrowsmith, Q Wu, D Nie, J Cruickshank, J Haight, YS Ji, F Ciamponi, ... | 3 | 2021 |
